Criminal Justice Alcohol Program Linked to Decreased Mortality Thursday, February 11, 2016 Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.Charting Kidney Cancer Metabolism Thursday, February 11, 2016 Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Sophia Genetics Partners with Swift Biosciences Thursday, February 11, 2016 Sophia Genetics launches a new combined genetic test solution in Europe by combining Swift Biosciences Accel-Amplicon™ panels with Sophia DDM™, the company’s analytics platform for molecular diagnosis.Individuals' Medical Histories Predicted by their Noncoding Genomes Thursday, February 11, 2016 Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.'Molecular Movie' Opens Door to New Cancer Treatments Thursday, February 11, 2016 An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.Advancing Synthetic Biology Thursday, February 11, 2016 Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.Genomics England, Illumina Enter Bioinformatics Partnership Thursday, February 11, 2016 Illumina, and Genomics England have announced a partnership to develop a platform and knowledge base that can be used to improve and automate genome interpretation. Novel Route to Serum Based Prostate Cancer Diagnostics Thursday, February 11, 2016 Protagen AG has announced the identification of novel protein biomarkers in prostate cancer, which are potential drug targets supporting novel strategies in precision medicine. Preparing for Potential Zika Outbreaks Wednesday, February 10, 2016 Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.